What's in ABRAXIS PHARM's pipeline?

ABRAXIS PHARM has 1 drugs in our index: 1 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with ABRAXIS PHARM's portfolio?

No competitive overlap detected.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/abraxis-pharm.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-15 · How we verify

ABRAXIS PHARM — Portfolio Competitive Intelligence Brief

ABRAXIS PHARM pipeline: 1 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Cupric Sulfate	copper sulfate	marketed	copper sulfate		Immunology	1987-01-01

Therapeutic area mix

Immunology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

2032-08-14 — Cupric Sulfate · 10188546 · Formulation · US
2032-08-14 — Cupric Sulfate · 10159596 · Formulation · US
2032-08-14 — Cupric Sulfate · 9427351 · Formulation · US
2032-08-14 — Cupric Sulfate · 11850181 · Formulation · US
2033-04-09 — Cupric Sulfate · 9089418 · Formulation · US
2033-10-18 — Cupric Sulfate · 12138199 · Formulation · US
2034-02-24 — Cupric Sulfate · 9610191 · Method of Use · US
2034-02-24 — Cupric Sulfate · 10398588 · Formulation · US
2034-03-22 — Cupric Sulfate · 10022264 · Formulation · US
2034-04-28 — Cupric Sulfate · 9265652 · Method of Use · US
2034-06-13 — Cupric Sulfate · 10166141 · Formulation · US
2034-08-16 — Cupric Sulfate · 11207209 · Formulation · US
2037-01-23 — Cupric Sulfate · 10918516 · Formulation · US

Competitive overlap (companies sharing drug classes)

No competitive overlap data.

Subscribe to ongoing alerts

Every new pipeline event for ABRAXIS PHARM:

Cite this brief

Drug Landscape (2026). ABRAXIS PHARM — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/abraxis-pharm. Accessed 2026-05-15.